LYRA logo

Lyra Therapeutics, Inc. (LYRA)

Profile

Full Name

Lyra Therapeutics, Inc.

Ticker

NASDAQ: LYRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 1, 2020

Indexes

Not included

Website

https://lyratherapeutics.com

Employees

30

Key Details

Price

$3.69(5.43%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.53M(-1.54% YoY)

Annual EPS

-$71.75(-5601.03% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.69
    LYRA price is $3.69

    30-Day Relative Volume

    0.66
    LYRA 30-day relative volume is 0.66

    Price Performance

    Price Most Recent Change

    +5.43%
    LYRA price was up +5.43% on Nov 28, 2025

    Price YTD Change

    -64.17%
    LYRA price is down -64.17% since January 1st

    Price 1-Year Change

    -64.35%
    LYRA price is down -64.35% year-on-year

    Price 3-Year Change

    -97.8%
    LYRA price is down -97.8% over the past 3 years

    Price Range

    Price All-Time High

    $1100.00
    LYRA price is currently -99.66% below its historical high of $1100.00

    Price 3-Year Low

    $2.84
    LYRA price is currently +29.93% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $4.89M
    LYRA market cap is $4.89 million

    Market Cap 3-Year Change

    -95.43%
    LYRA market cap is down -95.43% over the past 3 years

    Market Cap All-Time High

    $390.13M
    LYRA market cap is currently -98.75% below its historical high of $390.13 million

    Market Cap Sector Percentile

    10.84%
    LYRA market cap is higher than 10.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.23%
    LYRA shares outstanding is up +1.23% year-on-year

    Shares Outstanding 3-Year Change

    +108.22%
    LYRA shares outstanding is up +108.22% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.03
    LYRA beta is 1.03

    200-day SMA

    $7.55
    LYRA price is currently -51.11% below its 200-day simple moving average

    50-day SMA

    $5.74
    LYRA price is currently -35.69% below its 50-day simple moving average

    14-Day RSI

    36.89
    LYRA 14-day relative strength index is 36.89

    Volume

    0.66
    LYRA 30-day relative volume is 0.66

    ATR

    $0.45
    LYRA average true range is $0.45

    10-day Historical Volatility

    139.52%
    LYRA 10-day historical volatility is 139.52%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.53M
    LYRA annual revenue is $1.53 million

    Revenue Analysts Estimate

    $800.00K
    LYRA annual revenue is currently +91.75% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -1.54%
    LYRA annual revenue is down -1.54% year-on-year

    Revenue Sector Percentile

    38.38%
    LYRA annual revenue is higher than 38.38% of companies in Healthcare sector

    EPS

    EPS

    -$71.75
    LYRA annual earnings per share is -$71.75

    EPS Analysts Estimate

    -$1.50
    LYRA annual earnings per share is currently -4683.17% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -5601.03%
    LYRA annual earnings per share is down -5601.03% year-on-year

    EPS Sector Percentile

    4.28%
    LYRA annual earnings per share is higher than 4.28% of companies in Healthcare sector

    Profit

    Gross Profit

    $1.06M
    LYRA annual gross profit is $1.06 million

    Gross Margin

    69.30%
    LYRA annual gross profit margin is 69.30%

    Operating Profit

    -$60.73M
    LYRA annual operating income is -$60.73 million

    Operating Margin

    -3959.13%
    LYRA annual operating profit margin is -3959.13%

    Net Income

    -$93.44M
    LYRA annual net profit is -$93.44 million

    Net Margin

    -6090.94%
    LYRA annual net profit margin is -6090.94%

    Expenses

    Total Expenses

    $62.27M
    LYRA annual total expenses is $62.27 million

    Operating Expenses

    $62.27M
    LYRA annual total operating expenses is $62.27 million

    Cost Of Goods Sold

    $471.00K
    LYRA annual cost of goods sold is $471.00 thousand

    Selling, General & Administrative Expenses

    $18.50M
    LYRA annual SG&A is $18.50 million

    Depreciation & Amortization

    $471.00K
    LYRA annual D&A is $471.00 thousand

    Interest Expense

    $0.00
    LYRA annual interest expense is $0.00

    Income Tax

    $39.00K
    LYRA annual income tax is $39.00 thousand

    EBIT & EBITDA

    EBIT

    -$60.73M
    LYRA annual earnings before interest & taxes is -$60.73 million

    EBITDA

    -$60.26M
    LYRA annual EBITDA is -$60.26 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $66.35M
    LYRA annual total assets is $66.35 million

    Non Current Assets

    $23.32M
    LYRA annual long term assets is $23.32 million

    Current Assets

    $43.02M
    LYRA annual total current assets is $43.02 million

    Cash and Cash Equivalents

    $40.58M
    LYRA annual cash & cash equivalents is $40.58 million

    Accounts Receivable

    -
    LYRA annual accounts receivable value is unknown

    Inventory

    $0.00
    LYRA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $54.75M
    LYRA annual total liabilities is $54.75 million

    Long Term Liabilities

    $42.12M
    LYRA annual total long term liabilities is $42.12 million

    Current Liabilities

    $12.63M
    LYRA annual current liabilities is $12.63 million

    Accounts Payable

    $1.18M
    LYRA annual accounts payable is $1.18 million

    Debt

    Total Debt

    $34.38M
    LYRA annual total debt is $34.38 million

    Total Debt 1-Year Change

    +27.9%
    LYRA annual total debt is up +27.9% year-on-year

    Long Term Debt

    $30.26M
    LYRA annual long term debt is $30.26 million

    Short Term Debt

    $4.12M
    LYRA annual short term debt is $4.12 million

    Equity & Capital

    Shareholders Equity

    $11.59M
    LYRA annual stockholders equity is $11.59 million

    Book Value

    $11.59M
    LYRA annual book value is $11.59 million

    Retained Earnings

    -$404.79M
    LYRA annual retained earnings is -$404.79 million

    Working Capital

    $30.39M
    LYRA annual working capital is $30.39 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$70.01M
    LYRA annual cash from operations is -$70.01 million

    Cash From Operations 1-Year Change

    -10.59%
    LYRA annual cash from operations is down -10.59% year-on-year

    Cash From Investing

    $80.31M
    LYRA annual cash from investing is $80.31 million

    Cash From Investing 1-Year Change

    +738.15%
    LYRA annual cash from investing is up +738.15% year-on-year

    Cash From Financing

    $8.53M
    LYRA annual cash from financing is $8.53 million

    Cash From Financing 1-Year Change

    -87.01%
    LYRA annual cash from financing is down -87.01% year-on-year

    CAPEX

    CAPEX

    $2.34M
    LYRA annual capital expenditures is $2.34 million

    CAPEX 1-Year Change

    +123.3%
    LYRA annual capital expenditures is up +123.3% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$72.35M
    LYRA annual free cash flow is -$72.35 million

    Free Cash Flow 1-Year Change

    -12.43%
    LYRA annual free cash flow is down -12.43% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    69.30%
    LYRA annual gross profit margin is 69.30%

    Operating Margin

    -3959.13%
    LYRA annual operating profit margin is -3959.13%

    Net Margin

    -6090.94%
    LYRA annual net profit margin is -6090.94%

    ROA & ROE

    ROA

    -89.43%
    LYRA annual return on assets is -89.43%

    ROE

    -184.99%
    LYRA annual return on equity is -184.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LYRA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LYRA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -1.13
    LYRA price to book ratio is -1.13

    PB Ratio Sector Percentile

    10.23%
    LYRA price to book ratio is higher than 10.23% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    8.15
    LYRA price to sales ratio is 8.15

    PS Ratio Sector Percentile

    66.67%
    LYRA price to sales ratio is higher than 66.67% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $14.21M
    LYRA enterprise value is $14.21 million

    Enterprise Value Sector Percentile

    23.15%
    LYRA enterprise value is higher than 23.15% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.45
    LYRA EV/EBITDA is -0.45

    EV/EBITDA Sector Percentile

    54.42%
    LYRA EV/EBITDA is higher than 54.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.41
    LYRA annual current ratio is 3.41

    Quick Ratio

    3.41
    LYRA annual quick ratio is 3.41

    Leverage

    Debt To Equity

    0.00
    LYRA annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    LYRA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    1
    LYRA piotroski f-score is 1

    Altman Z-Score

    -10.94
    LYRA altman z-score is -10.94

    Analyst ratings

    Recent major analysts updates

    Aug 14, 25 HC Wainwright & Co.
    Neutral
    Jun 10, 25 HC Wainwright & Co.
    Neutral
    Mar 14, 25 HC Wainwright & Co.
    Neutral
    Aug 15, 24 HC Wainwright & Co.
    Neutral
    Aug 15, 24 Cantor Fitzgerald
    Overweight
    Jun 20, 24 Cantor Fitzgerald
    Overweight
    May 7, 24 Jefferies
    Hold
    May 7, 24 HC Wainwright & Co.
    Neutral
    May 6, 24 BTIG
    Neutral
    May 1, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LYRA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Lyra Therapeutics, Inc.?
    • Does Lyra Therapeutics, Inc. pay dividends?
    • What sector is Lyra Therapeutics, Inc. in?
    • What industry is Lyra Therapeutics, Inc. in?
    • What country is Lyra Therapeutics, Inc. based in?
    • When did Lyra Therapeutics, Inc. go public?
    • Is Lyra Therapeutics, Inc. in the S&P 500?
    • Is Lyra Therapeutics, Inc. in the NASDAQ 100?
    • Is Lyra Therapeutics, Inc. in the Dow Jones?
    • When was Lyra Therapeutics, Inc.'s last earnings report?
    • When does Lyra Therapeutics, Inc. report earnings?

    What is the ticker symbol for Lyra Therapeutics, Inc.?

    The ticker symbol for Lyra Therapeutics, Inc. is NASDAQ:LYRA

    Does Lyra Therapeutics, Inc. pay dividends?

    No, Lyra Therapeutics, Inc. does not pay dividends

    What sector is Lyra Therapeutics, Inc. in?

    Lyra Therapeutics, Inc. is in the Healthcare sector

    What industry is Lyra Therapeutics, Inc. in?

    Lyra Therapeutics, Inc. is in the Biotechnology industry

    What country is Lyra Therapeutics, Inc. based in?

    Lyra Therapeutics, Inc. is headquartered in United States

    When did Lyra Therapeutics, Inc. go public?

    Lyra Therapeutics, Inc.'s initial public offering (IPO) was on May 1, 2020

    Is Lyra Therapeutics, Inc. in the S&P 500?

    No, Lyra Therapeutics, Inc. is not included in the S&P 500 index

    Is Lyra Therapeutics, Inc. in the NASDAQ 100?

    No, Lyra Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Lyra Therapeutics, Inc. in the Dow Jones?

    No, Lyra Therapeutics, Inc. is not included in the Dow Jones index

    When was Lyra Therapeutics, Inc.'s last earnings report?

    Lyra Therapeutics, Inc.'s most recent earnings report was on November 12, 2025

    When does Lyra Therapeutics, Inc. report earnings?

    The date for Lyra Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page